Folate supplementation and cardiovascular disease (Q46807103)

25 December 2017

title

Folate supplementation and cardiovascular disease. (English)

1 reference

25 December 2017

main subject

cardiovascular disease

1 reference

1 reference

1

1 reference

25 December 2017

Shah Ebrahim

series ordinal

2

object named as

Shah Ebrahim

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

366

1 reference

25 December 2017

issue

9498

1 reference

25 December 2017

page(s)

1679-1681

1 reference

25 December 2017

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

A strategy to reduce cardiovascular disease by more than 80%

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Vitamin C and risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Secondary prevention with folic acid: effects on clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Folate therapy and in-stent restenosis after coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Taking folate in pregnancy and risk of maternal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

Vegetables, fruit, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967676-3

7 January 2021

10.1016/S0140-6736(05)67676-3

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017